Amarin Corp Nachrichten und Aktivitäten
Führungskräfte
Siehe das Organigramm mit seine 18 wichtigsten Führungskräfte
Die meist gesuchten Biographien bei Amarin Corp
- Aaron Berg, President and Chief Executive Officer
- Louis Sterling, Director
- Patrice Bonfiglio, Director
Eine Benachrichtigung erstellen
um Veränderungen bei Führungskräften von Amarin Corp nachzuverfolgen.
Pharmazie
Amarin Corp hat 1.920 Konkurrenten , einschließlich Sanofi (Frankreich), Moderna (USA) und Eli Lilly (USA).
Popular M&A news in Pharmazie
- Eli Lilly has announced the acquisition of AtaiBeckley (veröffentlicht am 17, Juli 2026).
- Agenus hat gerade eine Spendenaktion von 340 Millionen Dollar angekündigt. (veröffentlicht am 17, Juli 2026).
- GSK hat Nuvalent erworben (veröffentlicht am 17, Juli 2026).
Andere vorgeschlagene Kontakte der Pharmazie branche
Nachrichten
Neueste Pressemitteilungen nach Amarin Corp
- Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026 – Amarin Corp
- Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape – Amarin Corp
- New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia – Amarin Corp
- Amarin Reports 2026 First Quarter Financial Results – Amarin Corp
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 – Amarin Corp
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction – Amarin Corp
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline – Amarin Corp
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scientif
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology – Amarin Corp
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results – Amarin Corp
- View more press releases Close
Social media about Amarin Corp
- Amarin Corp auf Wikipedia, Google News & Yahoo Finance
- Amarin Corp auf LinkedIn, X (Twitter) & YouTube
